Invokana
Invokana Reduces Risk for Death From CVD
Canagliflozin significantly reduced the combined risk for death from cardiovascular disease, myocardial ...
JUNE 13, 2017
FDA Issues Warning Regarding Risk for Amputations With Diabetes Drug
The FDA issued a boxed warning for canagliflozin because it can increase the risk for leg and foot amputations.
MAY 23, 2017
New Class of Diabetes Drugs Raises Safety Questions
Serious concerns about safety and efficacy emerge after more than 2 million perscriptions written.
JULY 2, 2016
Load more